文献速递泌尿生殖MR

影像组学用于检测PI-RADS 3病变中的前列腺癌:系统综述与Meta分析

Radiomics for Detection of Prostate Cancer in PI-RADS 3 Lesions: A Systematic Review and Meta-analysis.
PubMed 文献 · Acad Radiol · 2025-06-20

该系统综述与Meta分析纳入12项研究、2367个PI-RADS 3病变(2340例患者),评估影像组学检测所有前列腺癌和临床显著前列腺癌的效能;验证集中合并敏感度均为0.76,特异度分别为0.79和0.82,AUC分别为0.78和0.77;作者认为影像组学准确性高,但原始研究数量和质量有限,需更多前瞻性大样本多中心研究。

要点

  • 验证集中影像组学检测PI-RADS 3病变中所有前列腺癌的合并敏感度0.76、特异度0.79、AUC 0.78。
  • 验证集中检测临床显著前列腺癌的合并敏感度0.76、特异度0.82、AUC 0.77。
  • 原始研究数量和质量有限,作者认为需更多前瞻性、大样本、多中心研究。

核心结论

  • 影像组学在检测PI-RADS 3病变中的前列腺癌方面具有较高准确性,但纳入原始研究的数量和质量均有限,作者认为未来有必要开展更多前瞻性、大样本、多中心研究。

研究设计与样本

  • 系统综述与Meta分析,系统检索Embase、PubMed、Cochrane Library和Web of Science截至2024年9月15日的文献,纳入12项研究、2367个PI-RADS 3病变(2340例患者),采用影像组学质量评分(RQS)进行质量评价。

诊断标准与关键数值

  • 验证集中,影像组学检测所有前列腺癌的合并敏感度0.76(95%CI 0.71-0.80)、特异度0.79(95%CI 0.72-0.85)、AUC 0.78(95%CI 0.32-0.96)。
  • 验证集中,影像组学检测临床显著前列腺癌的合并敏感度0.76(95%CI 0.71-0.80)、特异度0.82(95%CI 0.74-0.88)、AUC 0.77(95%CI 0.49-0.92)。

临床应用与阅片要点

  • 原文结论认为影像组学在检测PI-RADS 3病变中的前列腺癌方面具有较高准确性。
  • 原文指出纳入原始研究的数量和质量均有限,作者认为未来有必要开展更多前瞻性、大样本、多中心研究。

局限性

  • 纳入原始研究的数量有限。
  • 纳入原始研究的质量有限。
  • 作者认为未来有必要开展更多前瞻性、大样本、多中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The noninvasive diagnosis of prostate cancer (PCa) in Prostate Imaging-Reporting and Data System (PI-RADS) 3 lesions remains challenging. The effectiveness of radiomics for detecting PCa in PI-RADS 3 lesions has been explored in some studies, but systematic evidence is still lacking to date. Therefore, this study was conducted to synthesize the effectiveness of radiomics for detecting PCa in PI-RADS 3 lesions.

MATERIALS AND METHODS: A systematic search was conducted on Embase, PubMed, Cochrane Library, and Web of Science until September 15, 2024 for studies on the detection performance of radiomics for all PCa and clinically significant PCa (csPCa) in PI-RADS 3 lesions. Quality assessment was performed using the radiomics quality score (RQS).

RESULTS: Twelve studies were included, encompassing 2367 PI-RADS 3 lesions in 2340 patients. Meta-analyses revealed that in the validation set, the pooled sensitivity, specificity, and area under the summary receiver operating characteristic curve (AUC) of radiomics were 0.76 (95%CI 0.71-0.80), 0.79 (95%CI 0.72-0.85), and 0.78 (95%CI 0.32-0.96), respectively, for detecting all PCa. In the validation set, the pooled sensitivity, specificity, and AUC of radiomics were 0.76 (95%CI 0.71-0.80), 0.82 (95%CI 0.74-0.88), and 0.77 (95%CI 0.49-0.92), respectively, for detecting csPCa.

CONCLUSION: Radiomics possesses high accuracy in the detection of PCa in PI-RADS 3 lesions. However, both the number and quality of the original studies included were limited, so it is necessary to conduct more prospective, large-sample, multicenter studies in the future.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Q, Wang Y, Zhou B, et al. Radiomics for Detection of Prostate Cancer in PI-RADS 3 Lesions: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40541547. doi:10.1016/j.acra.2025.05.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。